特立帕肽在治疗糖皮质激素性骨质疏松症中的作用

被引:3
作者
戚怡
吴铁
机构
[1] 广东医学院药理学教研室
关键词
特立帕肽; 糖皮质激素; 骨质疏松; 综述文献;
D O I
暂无
中图分类号
R580 [];
学科分类号
摘要
糖皮质激素性骨质疏松症是最常见的继发性骨质疏松症,以骨形成受损为主要病理特征,目前治疗药物以抗骨吸收药物为主,作用单一,效果有限。特立帕肽即重组人甲状旁腺激素1-34,可以促进骨形成,增加骨密度,降低骨折风险。本文就糖皮质激素所造成的骨质疏松症及特立帕肽的应用研究作一综述。
引用
收藏
页码:454 / 455
页数:2
相关论文
共 8 条
[1]
Molecular and cellular mechanisms of the anabolic effect of intermittent PTH [J].
Jilka, Robert L. .
BONE, 2007, 40 (06) :1434-1446
[2]
Active comparator trial of teriparatide versus alendronate in the treatment of glucocorticoid-induced osteoporosis.[J].Kathleen A. Taylor.Journal of Clinical Densitometry.2007, 2
[3]
Glucocorticoid-induced osteoporosis: an update [J].
Mazziotti, Gherardo ;
Angeli, Alberto ;
Bilezikian, John P. ;
Canalis, Ernesto ;
Giustina, Andrea .
TRENDS IN ENDOCRINOLOGY AND METABOLISM, 2006, 17 (04) :144-149
[4]
Parathyroid hormone secretion and action: Evidence for discrete receptors for the carboxyl-terminal region and related biological actions of carboxyl-terminal ligands [J].
Murray, TM ;
Rao, LG ;
Divieti, P ;
Bringhurst, FR .
ENDOCRINE REVIEWS, 2005, 26 (01) :78-113
[5]
Daily treatment with parathyroid hormone is associated with an increase in vertebral cross-sectional area in postmenopausal women with glucocorticoid-induced osteoporosis [J].
Rehman, Q ;
Lang, TF ;
Arnaud, CD ;
Modin, GW ;
Lane, NE .
OSTEOPOROSIS INTERNATIONAL, 2003, 14 (01) :77-81
[6]
Bone tissue and its mineralization in aged estrogen-depleted rats after long-term intermittent treatment with parathyroid hormone (PTH) analog SDZ PTS 893 or human PTH(1-34) [J].
Kneissel, M ;
Boyde, A ;
Gasser, JA .
BONE, 2001, 28 (03) :237-250
[7]
Short-term increases in bone turnover markers predict parathyroid hormone-induced spinal bone mineral density gains in postmenopausal women with glucocorticoid-induced osteoporosis [J].
Lane, NE ;
Sanchez, S ;
Genant, HK ;
Jenkins, DK ;
Arnaud, CD .
OSTEOPOROSIS INTERNATIONAL, 2000, 11 (05) :434-442
[8]
Glucocorticoid treatment or food deprivation counteract the stimulating effect of growth hormone on rat cortical bone strength..rtoft G; Oxlund H; Jorgensen PH; Andreassen TT;.Acta Paediatr.1992,